BioLoomics
PrivateLast Round
Seed
Sep 19, 2023
Total Funding Raised
$10.12M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
BioLoomics is a biotechnology company that develops antibody-drug conjugates (ADCs) for cancer therapies using directed evolution, synthetic biology, and machine learning.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioLoomics Comparables
Compare BioLoomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Antiverse | 83% | |
| AvantGen, Inc. | 79% | |
| BigHat Biosciences | 77% |
BioLoomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 19, 2023 | ||||
| Pre Seed | May 11, 2021 | ||||
| Grant | Nov 21, 2019 | ||||
| Pre Seed | May 30, 2019 |
BioLoomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Boom Capital Ventures | Seed |
| Horizons Ventures | Seed |
| TechU Ventures | Seed |
| Innovation Endeavors | Seed |
| Boom Capital | Seed |
| BoxOne Ventures | Seed |
| Hummingbird Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 123% MoM, reaching 500.
- May 18, 2026
Monthly visitors grew 684% MoM to 1.3K.
BioLoomics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BioLoomics's valuation, stock price, and market status.
Is BioLoomics a public or private company?
BioLoomics is a private company.
What is the current stock price of BioLoomics?
BioLoomics is a private company with no public stock price. No recent secondary market data is available.
How much is BioLoomics worth (valuation)?
Valuation information for BioLoomics is not publicly available.
Can I buy BioLoomics stock?
BioLoomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was BioLoomics's last funding round?
BioLoomics's most recent funding round was Seed on September 19, 2023.
Who are the main investors in BioLoomics?
Key investors in BioLoomics include Innovation Endeavors.
Will BioLoomics IPO soon?
No public IPO plans have been announced for BioLoomics.
How can I track BioLoomics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BioLoomics's secondary market activity and sign up for updates.